STERIS EBITDA 2010-2025 | STE
STERIS annual and quarterly EBITDA history from 2010 to 2025. EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
- STERIS EBITDA for the quarter ending March 31, 2025 was $0.371B, a 0.17% decline year-over-year.
- STERIS EBITDA for the twelve months ending March 31, 2025 was $1.359B, a 30.18% decline year-over-year.
- STERIS 2024 annual EBITDA was $1.406B, a 23.66% decline from 2023.
- STERIS 2023 annual EBITDA was $1.842B, a 67.82% increase from 2022.
- STERIS 2022 annual EBITDA was $1.098B, a 42.99% increase from 2021.
| STERIS Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $1,406 |
| 2023 | $1,842 |
| 2022 | $1,098 |
| 2021 | $768 |
| 2020 | $734 |
| 2019 | $637 |
| 2018 | $578 |
| 2017 | $473 |
| 2016 | $357 |
| 2015 | $319 |
| 2014 | $282 |
| 2013 | $312 |
| 2012 | $285 |
| 2011 | $140 |
| 2010 | $260 |
| 2009 | $238 |
| STERIS Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-12-31 | $371 |
| 2024-09-30 | $335 |
| 2024-06-30 | $298 |
| 2024-03-31 | $355 |
| 2023-12-31 | $372 |
| 2023-09-30 | $344 |
| 2023-06-30 | $336 |
| 2023-03-31 | $895 |
| 2022-12-31 | $329 |
| 2022-09-30 | $321 |
| 2022-06-30 | $297 |
| 2022-03-31 | $358 |
| 2021-12-31 | $322 |
| 2021-09-30 | $320 |
| 2021-06-30 | $98 |
| 2021-03-31 | $203 |
| 2020-12-31 | $204 |
| 2020-09-30 | $196 |
| 2020-06-30 | $165 |
| 2020-03-31 | $209 |
| 2019-12-31 | $192 |
| 2019-09-30 | $176 |
| 2019-06-30 | $157 |
| 2019-03-31 | $191 |
| 2018-12-31 | $152 |
| 2018-09-30 | $153 |
| 2018-06-30 | $141 |
| 2018-03-31 | $157 |
| 2017-12-31 | $148 |
| 2017-09-30 | $144 |
| 2017-06-30 | $129 |
| 2017-03-31 | $110 |
| 2016-12-31 | $116 |
| 2016-09-30 | $120 |
| 2016-06-30 | $127 |
| 2016-03-31 | $152 |
| 2015-12-31 | $92 |
| 2015-09-30 | $46 |
| 2015-06-30 | $67 |
| 2015-03-31 | $90 |
| 2014-12-31 | $83 |
| 2014-09-30 | $81 |
| 2014-06-30 | $65 |
| 2014-03-31 | $80 |
| 2013-12-31 | $75 |
| 2013-09-30 | $68 |
| 2013-06-30 | $59 |
| 2013-03-31 | $86 |
| 2012-12-31 | $85 |
| 2012-09-30 | $78 |
| 2012-06-30 | $63 |
| 2012-03-31 | $91 |
| 2011-12-31 | $70 |
| 2011-09-30 | $63 |
| 2011-06-30 | $61 |
| 2011-03-31 | $72 |
| 2010-12-31 | $49 |
| 2010-09-30 | $68 |
| 2010-06-30 | $-50 |
| 2010-03-31 | $66 |
| 2009-12-31 | $74 |
| 2009-09-30 | $64 |
| 2009-06-30 | $57 |
| 2009-03-31 | $63 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $24.719B | $5.460B |
| STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $202.004B | 88.48 |
| Thermo Fisher Scientific (TMO) | United States | $155.550B | 18.82 |
| Edwards Lifesciences (EW) | United States | $45.755B | 30.00 |
| Alcon (ALC) | Switzerland | $44.308B | 29.94 |
| IDEXX Laboratories (IDXX) | United States | $41.667B | 47.88 |
| DexCom (DXCM) | United States | $33.517B | 51.81 |
| IQVIA Holdings (IQV) | United States | $24.708B | 13.84 |
| Mettler-Toledo (MTD) | United States | $24.055B | 28.61 |
| Waters (WAT) | United States | $21.392B | 30.18 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.121B | 0.00 |
| Hologic (HOLX) | United States | $12.655B | 13.75 |
| Penumbra (PEN) | United States | $10.870B | 85.31 |
| Sysmex ADR (SSMXY) | Japan | $10.657B | 30.23 |
| Masimo (MASI) | United States | $8.438B | 31.12 |
| Globus Medical (GMED) | United States | $8.424B | 19.76 |
| Teleflex (TFX) | United States | $5.713B | 9.43 |
| Glaukos (GKOS) | United States | $5.455B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.222B | 22.12 |
| TransMedics (TMDX) | United States | $4.112B | 89.40 |
| PROCEPT BioRobotics (PRCT) | United States | $3.213B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.421B | 14.42 |
| Veracyte (VCYT) | United States | $2.287B | 32.09 |
| Nihon Kohden (NHNKY) | Japan | $2.213B | 25.38 |
| Elekta AB (EKTAY) | Sweden | $2.048B | 18.41 |
| Alphatec Holdings (ATEC) | United States | $1.894B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.537B | 0.00 |
| Artivion (AORT) | United States | $1.260B | 118.04 |
| Pulse Biosciences (PLSE) | United States | $1.156B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.055B | 5.61 |
| SiBone (SIBN) | United States | $0.843B | 0.00 |
| IRadimed (IRMD) | United States | $0.685B | 34.78 |
| Mesa Laboratories (MLAB) | United States | $0.665B | 14.54 |
| Beta Bionics (BBNX) | United States | $0.623B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.43 |
| Delcath Systems (DCTH) | United States | $0.596B | 0.00 |
| RxSight (RXST) | United States | $0.577B | 0.00 |
| NeuroPace (NPCE) | United States | $0.574B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.560B | 0.00 |
| AxoGen (AXGN) | United States | $0.539B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.474B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.456B | 12.13 |
| Treace Medical Concepts (TMCI) | United States | $0.423B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.382B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.311B | 0.00 |
| Neuronetics (STIM) | United States | $0.278B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.196B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.184B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.166B | 0.00 |
| CVRx (CVRX) | United States | $0.165B | 0.00 |
| 908 Devices (MASS) | United States | $0.164B | 0.00 |
| Inogen (INGN) | United States | $0.164B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.150B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.141B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.125B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.092B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.074B | 44.60 |
| InspireMD (NSPR) | Israel | $0.072B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.063B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.063B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.051B | 15.50 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.036B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.034B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.029B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.011B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.005B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.45 |